Provectus Pharmaceuticals Inc (NYSEMKT:PVCT) Investor Alert: Lawsuit Alleges Misleading Statements
An investor who purchased shares of Provectus Pharmaceuticals Inc (NYSEMKT:PVCT), filed a lawsuit in the U.S. District Court for the Middle District of Tennessee over alleged violations of Federal Securities Laws by Provectus Biopharmaceuticals, Inc. (formerly Provectus Pharmaceuticals Inc) in connection with certain allegedly false and misleading statements made between December 17, 2013 and May 22, 2014.
View full press release